Article Details

Y-mAbs Therapeutics' (YMAB) "Buy" Rating Reaffirmed at HC Wainwright

Retrieved on: 2021-06-28 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Y-mAbs Therapeutics' (YMAB) "Buy" Rating Reaffirmed at HC Wainwright. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 284,888 shares of the company's stock worth $8,615,000 after acquiring an additional 179,831 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up